Longitudinal Associations of Dietary Fructose and Psychological Stress with Vascular Aging Index and Incident Cardiovascular Disease in the CARDIA Cohort

Meaghan Osborne; Alexa Bernard; Emily Falkowski; Deni Peterson; Anusha Vavilikolanu; Dragana Komnenov

doi:10.1101/2023.10.03.23296515

ABSTRACT

Background Cardiovascular disease (CVD) risk increases exponentially with age, largely due to vascular aging. We explored how dietary behaviors (sucrose, fructose, sodium, and potassium consumption) and endured psychological stress in young adult males and females impact the vascular aging index (VAI) and CVD risk by mid-life.

Methods Data were obtained from the Coronary Artery Risk Development in Young Adults Study, an ongoing longitudinal study. Included participants (n=2,656) had undergone carotid artery ultrasound Doppler scans at year 20 allowing VAIs to be calculated. Demographics, dietary data and depression scale scores were obtained at the initial visit. Regression analyses were used to assess the predictors of VAI 20 years later. Cox regression analyses were conducted to assess the risk of fatal and non-fatal CVD, hypertensive CVD, and stroke.

Results Predictors of vascular aging were found to be sex-specific. In females, CES-D scores at baseline were positively associated with VAI (B-weight=0.063, p=0.015). In males, sodium intake at year 20 positively predicted VAI (B-weight=0.145, p=0.003) and potassium intake inversely predicted VAI (B-weight=-0.160, p<0.001). On Cox regression analyses, BMI significantly predicted CVD, stroke, and death. In addition, fructose consumption at year 20 was a significant predictor of CVD risk while having blood pressure above 130/80 mmHg at baseline was significantly associated with stroke risk.

Conclusion Our findings support the promotion of nutrient-specific behavior changes (specifically, limiting fructose consumption) to prevent vascular aging in early adulthood and CVD risk in mid-life.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

None.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB# 063319MP2X, Wayne State University, Detroit, MI

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes